Valuation: Cegedim

Market Cap 143M 166M 133M 122M 230M 15.93B 232M 1.58B 614M 8B 625M 611M 26.44B P/E 2026 *
6.81x
P/E 2027 * 5.19x
Enterprise Value 305M 356M 285M 261M 491M 34.05B 496M 3.37B 1.31B 17.1B 1.34B 1.31B 56.53B EV / Sales 2026 *
0.46x
EV / Sales 2027 * 0.4x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day-0.78%
1 week+0.39%
Current month+2.20%
1 month+2.92%
3 months-10.35%
6 months-13.02%
Current year-24.01%
1 week 10.22
Extreme 10.22
10.36
1 month 9.91
Extreme 9.91
10.42
Current year 8.7
Extreme 8.7
14.15
1 year 8.7
Extreme 8.7
14.15
3 years 8.7
Extreme 8.7
20.7
5 years 8.7
Extreme 8.7
28.8
10 years 8.7
Extreme 8.7
42.7
Manager TitleAgeSince
Chief Executive Officer 83 2009-10-24
Director of Finance/CFO - 2016-06-13
Corporate Officer/Principal 55 2015-11-25
Director TitleAgeSince
Chairman 83 2009-10-24
Director/Board Member 72 2010-08-08
Director/Board Member 55 2009-10-25
Change 5-day change 1-year change 3-year change Capi.($)
-0.78%+0.39% - - 166M
+3.10%-2.69%-38.03%+25.68% 422B
+1.34%+4.43%-19.12%+47.43% 253B
-0.98%+3.61%-27.56%+14.34% 133B
-1.13%-1.56%-33.16%+12.98% 46.81B
+6.10%+28.17%-66.70%+261.90% 45.82B
+1.99%+8.00%-17.18%+39.02% 25.33B
+3.74%+5.44%-16.73%+70.50% 21.18B
+4.07%+7.75%-11.59%+137.94% 15.75B
+0.96%+4.60%-27.04%+15.60% 14.05B
Average +1.84%+6.42%-28.57%+69.49% 108.57B
Weighted average by Cap. +2.00%+2.24%-31.23%+43.23%

Financials

2026 *2027 *
Net sales 660M 770M 617M 565M 1.06B 73.71B 1.07B 7.29B 2.84B 37.01B 2.89B 2.83B 122B 684M 799M 640M 585M 1.1B 76.45B 1.11B 7.56B 2.95B 38.39B 3B 2.93B 127B
Net income 21.3M 24.87M 19.93M 18.23M 34.3M 2.38B 34.69M 236M 91.73M 1.2B 93.37M 91.33M 3.95B 28M 32.69M 26.2M 23.96M 45.09M 3.13B 45.6M 310M 121M 1.57B 123M 120M 5.2B
Net Debt 162M 189M 152M 139M 261M 18.12B 264M 1.79B 698M 9.1B 711M 695M 30.08B 134M 156M 125M 114M 215M 14.95B 218M 1.48B 576M 7.51B 586M 574M 24.82B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Date Price Change
26-08-21 €10.22 -0.78%
26-08-20 €10.30 -0.19%
26-08-19 €10.32 -0.39%
26-08-18 €10.36 +0.97%
26-08-17 €10.26 +0.79%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.38EUR
Average target price
15.50EUR
Spread / Average Target
+49.33%

Quarterly revenue - Rate of surprise